Scope and consequences of peptic ulcer disease: How important is asymptomatic Helicobacter pylori infection?

Postgraduate Medicine

Volumn 105, Issue 3, 1999, Pages 100-110

  Graham, David Y ^a   Rakel, Robert E ^a   Fendrick, A Mark ^a   Go, Mae F ^a   Marshall, Barry J ^a   Peura, David A ^a   Scherger, Joseph E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE TRANSMISSION; DUODENUM ULCER; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; PEPTIC ULCER; PREVALENCE; RISK FACTOR; STOMACH MUCOSA; STOMACH ULCER;

EID: 0032932510     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.03.593     Document Type: Conference Paper

References (38)

1. Isenberg JI, Soll AH. Epidemiology, clinical manifestations, and diagnosis of peptic ulcer. In: Bennett JC, Plum F, eds. Cecil textbook of medicine. 20th ed. Philadelphia: Saunders, 1996:664-6
2. Peura DA. Helicobacter pylori and ulcerogenesis. Am J Med 1996; 100(5A):19S-25S; discussion 25S-26S
3. Howden CW. Clinical expressions of Helicobacter pylori infection. Am J Med 1996;100(5A):27S-32S; discussion 32S-34S
4. Graham DY. Can therapy even be denied for Helicobacter pylori infection? Gastroenterology 1997;113(6 Suppl):S113-7
5. Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India: comparison of developing and developed countries. Dig Dis Sci 1991;36(8):1084-8
6. Breuer T, Malaty HM, Graham DY. The epidemiology of H pylori-associated gastroduodenal diseases. In: Ernst PB, Michetti P, Smith PD, eds. The immunobiology of H pylori: from pathogenesis to prevention. Philadelphia: Lippincott-Raven, 1997:1-14
7. Smoak BL, Kelley PW, Taylor DN. Seroprevalence of Helicobacter pylori infections in a cohort of US Army recruits. Am J Epidemiol 1994;139(5):513-9
8. Staat MA, Kruszon-Moran D, McQuillan GM, et al. A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States. J Infect Dis 1996;174(5):1120-3
9. Parsonnet J, Blaser MJ, Perez-Perez GI, et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102(1):41-6
10. Cave DR. Transmission and epidemiology of Helicobacter pylori. Am J Med 1996;100(5A):12S-17S; discussion 17S-18S
11. Graham DY, Malaty HM, Evans DG, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology 1991;100(6):1495-501
12. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35(6):742-5
13. Malaty HM, Evans DG, Evans DJ Jr, et al. Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology 1992;103(3):813-6
14. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34(12):1672-6
15. Tytgat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993; 22(1):127-39
16. Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis 1996;5(4):191-202
17. Jyotheeswaran S, Shah AN, Jin HO, et al. Prevalence of Helicobacter pylori in peptic ulcer patients in Greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998;93(4):574-8
18. Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998;26(1):60-3
19. Wilhoite SL, Ferguson DA Jr, Soike DR, et al. Increased prevalence of Helicobacter pylori antibodies among nurses. Arch Intern Med 1993;153(6):708-12
20. Hulten K, Han SW, Enroth H, et al. Helicobacter pylori in the drinking water in Peru. Gastroenterology 1996;110(4):1031-5
21. Mitchell HM, Li YY, Hu PJ, et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166(1):149-53
22. Han SW, Evans DG, el-Zaatari FA, et al. The interaction of pH, bile, and Helicobocter pylori may explain duodenal ulcer. Am J Gastroenterol 1996;91(6):1135-7
23. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90(12):5791-5
24. Mitchell HM, Hazell SL, Li YY, et al. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91(9):1785-8
25. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34(10):1339-43
26. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58(3): 603-10
27. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338(8763):332-5
28. Graham DY, Yamaoka Y. H pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998;3(3):145-51
29. Cover TL, Cao P, Lind CD, et al. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993;61(12):5008-12
30. Mobley HL. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med 1996;100(5A):2S-9S; discussion 9S-11S
31. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113(6):1983-91
32. Umlauft F, Keeffe EB, Offner F, et al. Helicobacter pylori infection and blood group-antigens: lack of clinical association. Am J Gastroenterol 1996;91(10):2135-8
33. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France, Jan 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241
34. Vanden Heule B, Van Kerkem C, Heimann R. Benign and malignant lymphoid lesions of the stomach: a histological reappraisal in the light of the Kiel classification for non-Hodgkin's lymphomas. Histopathology 1979;3(4):309-20
35. Bayerdorffer E, Miehlke S, Neubauer A, et al. Gastric MALT-lymphoma and Helicobocter pylori infection. Aliment Pharmacol Ther 1997;11(Suppl 1):89-94
36. Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. JAMA 1996;275(12):937-9
37. Faber K. Chronic gastritisuits relation to achylia and ulcer. Lancet 1927;2:902-7
38. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet: 1997;349(9057):1020-2